Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
royalty payments
Pharma
Ligand lays out $739M for royalty aggregator compatriot Xoma
After Xoma Royalty went on a dealmaking spree last year, the biotech royalty aggregator is being bought out by its peer Ligand Pharmaceuticals.
Fraiser Kansteiner
Apr 27, 2026 10:19am
BeOne bags $885M in Royalty deal on Amgen's Imdelltra
Aug 25, 2025 10:34am
Syndax strikes $350M funding deal with Royalty Pharma
Nov 5, 2024 10:50am
Ferring cuts ribbon at new gene therapy manufacturing hub
Oct 3, 2024 12:07pm
Penn sues BioNTech over Comirnaty royalties
Aug 7, 2024 7:30am
BioNTech hit with 'notice of default' in COVID royalty dispute
Mar 25, 2024 9:35am
